Product information

From Health Canada

Current status:

Cancelled Pre Market

Current status date:

2021-04-09

Original market date: See footnote 1

Product name:

ERYTHROMYCIN STEARATE TABLETS USP 250MG

DIN:

02235887 Electronic product monograph is not available

Company:

LABORATOIRES CONFAB INC
4355 Boul. Sir Wilfrid Laurier
St-Hubert
Quebec
Canada J3Y 3X3

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

08:12.12.04 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J01FA01 ERYTHROMYCIN

Active ingredient group (AIG) number:See footnote5

0105708003

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
ERYTHROMYCIN (ERYTHROMYCIN STEARATE) 250 MG / CAP
Version 4.0.3

"Page details"

Date modified: